Tapewire

Nasdaq · USD

SPRY

ARS Pharmaceuticals, Inc.

Export transactions ↓
Tapewire entity
883
SEC CIK
0001671858
Parsed reports
268

Last 12 months

Inside the activity.

0 purchase rows · 5 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202503
Dec 202500
Jan 202600
Feb 202600
Mar 202600
Apr 202600
May 202600
Jun 202602
Jul 202600
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
December 17, 2024 Filed Dec 19, 2024 21:20 UTC
Lowenthal Richard EDirector · PRESIDENT AND CEO · 10% owner
SaleCommon Stock 50,000 $11.67 $583,575.00
Disclosure

SEC source: 0001415889-24-029851 · form4-12192024_041201.xml · nonDerivative · entry 2

Lowenthal Richard E · CIK 0001378550 · Director · PRESIDENT AND CEO · 10% owner

10b5-1 filing: Plan reported

Ownership: Indirect · By Sarina Tanimoto Charitable Remainder UniTrust Dated January 7, 2020

Disclosed balance after: 1,297,447

F1 · shares: The shares were sold pursuant to a Rule 10b5-1 trading plan entered into on March 31, 2023.

F2 · price: The weighted average sale price for the transaction reported was $11.6715 and the range of prices were between $11.56 and $11.95. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.

F3 · ownership.nature: The Reporting Person's spouse is trustee of the trust. The Reporting Person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.

Read SEC document
December 13, 2024 Filed Dec 14, 2024 00:53 UTC
Chakma JustinChief Business Officer
Exercise / conversionStock Option (Right to Buy) · Derivative 27,272 $0.00 Strike: $1.44 $0.00
Disclosure

SEC source: 0001415889-24-029377 · form4-12142024_121217.xml · derivative · entry 6

Chakma Justin · CIK 0001951238 · Chief Business Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 55,461

Underlying: Common Stock · 27,272 shares

Expires 2031-12-13

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: Immediately exercisable.

Read SEC document
December 13, 2024 Filed Dec 14, 2024 00:53 UTC
Chakma JustinChief Business Officer
SaleCommon Stock 27,272 $12.06 $328,968.50
Disclosure

SEC source: 0001415889-24-029377 · form4-12142024_121217.xml · nonDerivative · entry 4

Chakma Justin · CIK 0001951238 · Chief Business Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 136,380

F2 · price: The weighted average sale price for the transaction reported was $12.0625, and the range of prices were between $11.83 and $12.28. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each price will be provided.

Read SEC document
December 13, 2024 Filed Dec 14, 2024 00:53 UTC
Chakma JustinChief Business Officer
Exercise / conversionCommon Stock 27,272 $1.44 $39,271.68
Disclosure

SEC source: 0001415889-24-029377 · form4-12142024_121217.xml · nonDerivative · entry 3

Chakma Justin · CIK 0001951238 · Chief Business Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 163,652

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
December 12, 2024 Filed Dec 14, 2024 00:53 UTC
Chakma JustinChief Business Officer
Exercise / conversionStock Option (Right to Buy) · Derivative 117,333 $0.00 Strike: $0.84 $0.00
Disclosure

SEC source: 0001415889-24-029377 · form4-12142024_121217.xml · derivative · entry 5

Chakma Justin · CIK 0001951238 · Chief Business Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 119,047

Underlying: Common Stock · 117,333 shares

Expires 2029-07-04

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: Immediately exercisable.

Read SEC document
December 12, 2024 Filed Dec 14, 2024 00:53 UTC
Chakma JustinChief Business Officer
SaleCommon Stock 117,333 $12.27 $1,439,124.44
Disclosure

SEC source: 0001415889-24-029377 · form4-12142024_121217.xml · nonDerivative · entry 2

Chakma Justin · CIK 0001951238 · Chief Business Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 136,380

F1 · price: The weighted average sale price for the transaction reported was $12.2653, and the range of prices were between $11.83 and $12.67. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each price will be provided.

Read SEC document
December 12, 2024 Filed Dec 14, 2024 00:53 UTC
Chakma JustinChief Business Officer
Exercise / conversionCommon Stock 117,333 $0.84 $98,559.72
Disclosure

SEC source: 0001415889-24-029377 · form4-12142024_121217.xml · nonDerivative · entry 1

Chakma Justin · CIK 0001951238 · Chief Business Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 253,713

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
December 12, 2024 Filed Dec 14, 2024 00:52 UTC
Dorsey BrianChief Operating Officer
Exercise / conversionStock Option (Right to Buy) · Derivative 25,000 $0.00 Strike: $0.64 $0.00
Disclosure

SEC source: 0001415889-24-029376 · form4-12142024_121223.xml · derivative · entry 6

Dorsey Brian · CIK 0001380762 · Chief Operating Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 21,828

Underlying: Common Stock · 25,000 shares

Expires 2028-11-28

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: Immediately exercisable.

Read SEC document
December 12, 2024 Filed Dec 14, 2024 00:52 UTC
Dorsey BrianChief Operating Officer
SaleCommon Stock 25,000 $12.30 $307,432.50
Disclosure

SEC source: 0001415889-24-029376 · form4-12142024_121223.xml · nonDerivative · entry 4

Dorsey Brian · CIK 0001380762 · Chief Operating Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 6,024

F3 · price: The weighted average sale price for the transaction report was $12.2973, and the range of prices were between $12.13 and $12.60. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.

Read SEC document
December 12, 2024 Filed Dec 14, 2024 00:52 UTC
Dorsey BrianChief Operating Officer
Exercise / conversionCommon Stock 25,000 $0.64 $16,000.00
Disclosure

SEC source: 0001415889-24-029376 · form4-12142024_121223.xml · nonDerivative · entry 3

Dorsey Brian · CIK 0001380762 · Chief Operating Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 31,024

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
December 11, 2024 Filed Dec 14, 2024 00:52 UTC
Dorsey BrianChief Operating Officer
Exercise / conversionStock Option (Right to Buy) · Derivative 15,000 $0.00 Strike: $0.64 $0.00
Disclosure

SEC source: 0001415889-24-029376 · form4-12142024_121223.xml · derivative · entry 5

Dorsey Brian · CIK 0001380762 · Chief Operating Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 46,828

Underlying: Common Stock · 15,000 shares

Expires 2028-11-28

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: Immediately exercisable.

Read SEC document
December 11, 2024 Filed Dec 14, 2024 00:52 UTC
Dorsey BrianChief Operating Officer
SaleCommon Stock 15,000 $12.43 $186,426.00
Disclosure

SEC source: 0001415889-24-029376 · form4-12142024_121223.xml · nonDerivative · entry 2

Dorsey Brian · CIK 0001380762 · Chief Operating Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 6,024

F1 · kind: The shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 31, 2023.

F2 · price: The weighted average sale price for the transaction report was $12.4284, and the range of prices were between $12.34 and $12.49. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.

Read SEC document
December 11, 2024 Filed Dec 14, 2024 00:52 UTC
Dorsey BrianChief Operating Officer
Exercise / conversionCommon Stock 15,000 $0.64 $9,600.00
Disclosure

SEC source: 0001415889-24-029376 · form4-12142024_121223.xml · nonDerivative · entry 1

Dorsey Brian · CIK 0001380762 · Chief Operating Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 21,024

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
December 10, 2024 Filed Dec 11, 2024 23:30 UTC
Tanimoto SarinaCHIEF MEDICAL OFFICER · 10% owner
SaleCommon Stock 50,000 $13.16 $658,155.00
Disclosure

SEC source: 0001415889-24-029012 · form4-12112024_061203.xml · nonDerivative · entry 3

Tanimoto Sarina · CIK 0001951291 · CHIEF MEDICAL OFFICER · 10% owner

10b5-1 filing: Plan reported

Ownership: Indirect · By Lowenthal-Tanimoto Family Trust U/A DTD 4/3/2006

Disclosed balance after: 1,148,499

F1 · shares: The shares were sold pursuant to a Rule 10b5-1 trading plan entered into on March 31, 2023.

F4 · price: The weighted average sale price for the transaction reported was $13.1631, and the range of prices were between $12.94 and $13.535. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.

F5 · ownership.nature: The shares are held in trust for the benefit of the Reporting Person and her spouse. The Reporting Person and her spouse are trustees of the trust.

Read SEC document
December 10, 2024 Filed Dec 11, 2024 23:30 UTC
Tanimoto SarinaCHIEF MEDICAL OFFICER · 10% owner
SaleCommon Stock 50,000 $13.17 $658,265.00
Disclosure

SEC source: 0001415889-24-029012 · form4-12112024_061203.xml · nonDerivative · entry 2

Tanimoto Sarina · CIK 0001951291 · CHIEF MEDICAL OFFICER · 10% owner

10b5-1 filing: Plan reported

Ownership: Indirect · By Richard Lowenthal Charitable Remainder UniTrust Dated January 7, 2020

Disclosed balance after: 1,246,494

F1 · shares: The shares were sold pursuant to a Rule 10b5-1 trading plan entered into on March 31, 2023.

F2 · price: The weighted average sale price for the transaction report was $13.1653, and the range of prices were between $12.94 and $13.535. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.

F3 · ownership.nature: The Reporting Person's spouse is trustee of the trust. The Reporting Person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.

Read SEC document
December 10, 2024 Filed Dec 11, 2024 23:30 UTC
Lowenthal Richard EDirector · PRESIDENT AND CEO · 10% owner
SaleCommon Stock 50,000 $13.16 $658,155.00
Disclosure

SEC source: 0001415889-24-029011 · form4-12112024_061201.xml · nonDerivative · entry 3

Lowenthal Richard E · CIK 0001378550 · Director · PRESIDENT AND CEO · 10% owner

10b5-1 filing: Plan reported

Ownership: Indirect · By Lowenthal-Tanimoto Family Trust U/A DTD 4/3/2006

Disclosed balance after: 1,148,499

F1 · shares: The shares were sold pursuant to a Rule 10b5-1 trading plan entered into on March 31, 2023.

F4 · price: The weighted average sale price for the transaction reported was $13.1631, and the range of prices were between $12.94 and $13.535. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.

F5 · ownership.nature: The shares are held in trust for the benefit of the Reporting Person and his spouse. The Reporting Person and his spouse are trustees of the trust.

Read SEC document
December 10, 2024 Filed Dec 11, 2024 23:30 UTC
Lowenthal Richard EDirector · PRESIDENT AND CEO · 10% owner
SaleCommon Stock 50,000 $13.17 $658,265.00
Disclosure

SEC source: 0001415889-24-029011 · form4-12112024_061201.xml · nonDerivative · entry 2

Lowenthal Richard E · CIK 0001378550 · Director · PRESIDENT AND CEO · 10% owner

10b5-1 filing: Plan reported

Ownership: Indirect · By Richard E. Lowenthal Charitable Remainder UniTrust Dated January 7, 2020

Disclosed balance after: 1,246,494

F1 · shares: The shares were sold pursuant to a Rule 10b5-1 trading plan entered into on March 31, 2023.

F2 · price: The weighted average sale price for the transaction reported was $13.1653, and the range of prices were between $12.94 and $13.535. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.

F3 · ownership.nature: The Reporting Person is trustee of the trust.

Read SEC document
December 10, 2024 Filed Dec 12, 2024 22:41 UTC
Chakma JustinChief Business Officer
Exercise / conversionStock Option (Right to Buy) · Derivative 50,000 $0.00 Strike: $0.84 $0.00
Disclosure

SEC source: 0001415889-24-029162 · form4-12122024_101220.xml · derivative · entry 3

Chakma Justin · CIK 0001951238 · Chief Business Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 50,000 shares

Expires 2029-07-04

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: Immediately exercisable.

Read SEC document
December 10, 2024 Filed Dec 12, 2024 22:41 UTC
Chakma JustinChief Business Officer
SaleCommon Stock 50,000 $13.15 $657,625.00
Disclosure

SEC source: 0001415889-24-029162 · form4-12122024_101220.xml · nonDerivative · entry 2

Chakma Justin · CIK 0001951238 · Chief Business Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 136,380

F1 · price: The weighted average sale price for the transaction reported was $13.1525, and the range of prices were between $12.95 and $13.42. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each price will be provided.

Read SEC document
December 10, 2024 Filed Dec 12, 2024 22:41 UTC
Chakma JustinChief Business Officer
Exercise / conversionCommon Stock 50,000 $0.84 $42,000.00
Disclosure

SEC source: 0001415889-24-029162 · form4-12122024_101220.xml · nonDerivative · entry 1

Chakma Justin · CIK 0001951238 · Chief Business Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 186,380

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
December 06, 2024 Filed Dec 7, 2024 00:15 UTC
Chakma JustinChief Business Officer
Exercise / conversionStock Option (Right to Buy) · Derivative 50,000 $0.00 Strike: $0.84 $0.00
Disclosure

SEC source: 0001415889-24-028567 · form4-12072024_121247.xml · derivative · entry 9

Chakma Justin · CIK 0001951238 · Chief Business Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 50,000

Underlying: Common Stock · 50,000 shares

Expires 2029-07-04

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: Immediately exercisable.

Read SEC document
December 06, 2024 Filed Dec 7, 2024 00:15 UTC
Chakma JustinChief Business Officer
SaleCommon Stock 50,000 $14.23 $711,615.00
Disclosure

SEC source: 0001415889-24-028567 · form4-12072024_121247.xml · nonDerivative · entry 6

Chakma Justin · CIK 0001951238 · Chief Business Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 136,380

F3 · price: The weighted average sale price for the transaction reported was $14.2323, and the range of prices were between $14.00 and $14.48. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each price will be provided.

Read SEC document
December 06, 2024 Filed Dec 7, 2024 00:15 UTC
Chakma JustinChief Business Officer
Exercise / conversionCommon Stock 50,000 $0.84 $42,000.00
Disclosure

SEC source: 0001415889-24-028567 · form4-12072024_121247.xml · nonDerivative · entry 5

Chakma Justin · CIK 0001951238 · Chief Business Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 186,380

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
December 06, 2024 Filed Dec 9, 2024 22:43 UTC
Tanimoto SarinaCHIEF MEDICAL OFFICER · 10% owner
Exercise / conversionStock Option (right to buy) · Derivative 11,876 $0.00 Strike: $8.42 $0.00
Disclosure

SEC source: 0001415889-24-028692 · form4-12092024_101228.xml · derivative · entry 9

Tanimoto Sarina · CIK 0001951291 · CHIEF MEDICAL OFFICER · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · By Spouse

Disclosed balance after: 1,088,124

Underlying: Common Stock · 11,876 shares

Expires 2033-01-02

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: 25% of the shares subject to the option vested on the one year anniversary of the vesting commencement date and the balance of the shares vest in a series of thirty-six (36) successive equal monthly installments measured from the first anniversary of the vesting commencement date.

Read SEC document
December 06, 2024 Filed Dec 9, 2024 22:43 UTC
Tanimoto SarinaCHIEF MEDICAL OFFICER · 10% owner
Exercise / conversionStock Option (right to buy) · Derivative 11,876 $0.00 Strike: $8.42 $0.00
Disclosure

SEC source: 0001415889-24-028692 · form4-12092024_101228.xml · derivative · entry 8

Tanimoto Sarina · CIK 0001951291 · CHIEF MEDICAL OFFICER · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 338,124

Underlying: Common Stock · 11,876 shares

Expires 2033-01-02

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: 25% of the shares subject to the option vested on the one year anniversary of the vesting commencement date and the balance of the shares vest in a series of thirty-six (36) successive equal monthly installments measured from the first anniversary of the vesting commencement date.

Read SEC document
December 06, 2024 Filed Dec 9, 2024 22:43 UTC
Tanimoto SarinaCHIEF MEDICAL OFFICER · 10% owner
Exercise / conversionStock Option (right to buy) · Derivative 13,789 $0.00 Strike: $1.44 $0.00
Disclosure

SEC source: 0001415889-24-028692 · form4-12092024_101228.xml · derivative · entry 7

Tanimoto Sarina · CIK 0001951291 · CHIEF MEDICAL OFFICER · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 20,684

Underlying: Common Stock · 13,789 shares

Expires 2031-12-13

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: 25% of the shares subject to the option vested on the one year anniversary of the vesting commencement date and the balance of the shares vest in a series of thirty-six (36) successive equal monthly installments measured from the first anniversary of the vesting commencement date.

Read SEC document
December 06, 2024 Filed Dec 9, 2024 22:43 UTC
Tanimoto SarinaCHIEF MEDICAL OFFICER · 10% owner
Exercise / conversionCommon Stock 11,876 $8.42 $99,995.92
Disclosure

SEC source: 0001415889-24-028692 · form4-12092024_101228.xml · nonDerivative · entry 3

Tanimoto Sarina · CIK 0001951291 · CHIEF MEDICAL OFFICER · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · By Spouse

Disclosed balance after: 4,327,189

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
December 06, 2024 Filed Dec 9, 2024 22:43 UTC
Tanimoto SarinaCHIEF MEDICAL OFFICER · 10% owner
Exercise / conversionCommon Stock 11,876 $8.42 $99,995.92
Disclosure

SEC source: 0001415889-24-028692 · form4-12092024_101228.xml · nonDerivative · entry 2

Tanimoto Sarina · CIK 0001951291 · CHIEF MEDICAL OFFICER · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,433,512

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
December 06, 2024 Filed Dec 9, 2024 22:43 UTC
Tanimoto SarinaCHIEF MEDICAL OFFICER · 10% owner
Exercise / conversionCommon Stock 13,789 $1.44 $19,856.16
Disclosure

SEC source: 0001415889-24-028692 · form4-12092024_101228.xml · nonDerivative · entry 1

Tanimoto Sarina · CIK 0001951291 · CHIEF MEDICAL OFFICER · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,421,636

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
December 06, 2024 Filed Dec 9, 2024 22:25 UTC
Lowenthal Richard EDirector · PRESIDENT AND CEO · 10% owner
Exercise / conversionStock Option (right to buy) · Derivative 11,876 $0.00 Strike: $8.42 $0.00
Disclosure

SEC source: 0001415889-24-028678 · form4-12092024_101253.xml · derivative · entry 9

Lowenthal Richard E · CIK 0001378550 · Director · PRESIDENT AND CEO · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · By Spouse

Disclosed balance after: 338,124

Underlying: Common Stock · 11,876 shares

Expires 2033-01-02

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: 25% of the shares subject to the option vested on the one year anniversary of the vesting commencement date and the balance of the shares vest in a series of thirty-six (36) successive equal monthly installments measured from the first anniversary of the vesting commencement date.

Read SEC document
December 06, 2024 Filed Dec 9, 2024 22:25 UTC
Lowenthal Richard EDirector · PRESIDENT AND CEO · 10% owner
Exercise / conversionStock Option (right to buy) · Derivative 13,789 $0.00 Strike: $1.44 $0.00
Disclosure

SEC source: 0001415889-24-028678 · form4-12092024_101253.xml · derivative · entry 8

Lowenthal Richard E · CIK 0001378550 · Director · PRESIDENT AND CEO · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · By Spouse

Disclosed balance after: 20,684

Underlying: Common Stock · 13,789 shares

Expires 2031-12-13

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: 25% of the shares subject to the option vested on the one year anniversary of the vesting commencement date and the balance of the shares vest in a series of thirty-six (36) successive equal monthly installments measured from the first anniversary of the vesting commencement date.

Read SEC document
December 06, 2024 Filed Dec 9, 2024 22:25 UTC
Lowenthal Richard EDirector · PRESIDENT AND CEO · 10% owner
Exercise / conversionStock Option (right to buy) · Derivative 11,876 $0.00 Strike: $8.42 $0.00
Disclosure

SEC source: 0001415889-24-028678 · form4-12092024_101253.xml · derivative · entry 7

Lowenthal Richard E · CIK 0001378550 · Director · PRESIDENT AND CEO · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,088,124

Underlying: Common Stock · 11,876 shares

Expires 2033-01-02

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: 25% of the shares subject to the option vested on the one year anniversary of the vesting commencement date and the balance of the shares vest in a series of thirty-six (36) successive equal monthly installments measured from the first anniversary of the vesting commencement date.

Read SEC document
December 06, 2024 Filed Dec 9, 2024 22:25 UTC
Lowenthal Richard EDirector · PRESIDENT AND CEO · 10% owner
Exercise / conversionCommon Stock 11,876 $8.42 $99,995.92
Disclosure

SEC source: 0001415889-24-028678 · form4-12092024_101253.xml · nonDerivative · entry 3

Lowenthal Richard E · CIK 0001378550 · Director · PRESIDENT AND CEO · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · By Spouse

Disclosed balance after: 3,433,512

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
December 06, 2024 Filed Dec 9, 2024 22:25 UTC
Lowenthal Richard EDirector · PRESIDENT AND CEO · 10% owner
Exercise / conversionCommon Stock 13,789 $1.44 $19,856.16
Disclosure

SEC source: 0001415889-24-028678 · form4-12092024_101253.xml · nonDerivative · entry 2

Lowenthal Richard E · CIK 0001378550 · Director · PRESIDENT AND CEO · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · By Spouse

Disclosed balance after: 3,421,636

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
December 06, 2024 Filed Dec 9, 2024 22:25 UTC
Lowenthal Richard EDirector · PRESIDENT AND CEO · 10% owner
Exercise / conversionCommon Stock 11,876 $8.42 $99,995.92
Disclosure

SEC source: 0001415889-24-028678 · form4-12092024_101253.xml · nonDerivative · entry 1

Lowenthal Richard E · CIK 0001378550 · Director · PRESIDENT AND CEO · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,327,189

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
December 05, 2024 Filed Dec 7, 2024 00:15 UTC
Chakma JustinChief Business Officer
Exercise / conversionStock Option (Right to Buy) · Derivative 49,640 $0.00 Strike: $0.84 $0.00
Disclosure

SEC source: 0001415889-24-028567 · form4-12072024_121247.xml · derivative · entry 8

Chakma Justin · CIK 0001951238 · Chief Business Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 100,000

Underlying: Common Stock · 49,640 shares

Expires 2029-07-04

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: Immediately exercisable.

Read SEC document
December 05, 2024 Filed Dec 7, 2024 00:15 UTC
Chakma JustinChief Business Officer
SaleCommon Stock 49,640 $14.13 $701,641.54
Disclosure

SEC source: 0001415889-24-028567 · form4-12072024_121247.xml · nonDerivative · entry 4

Chakma Justin · CIK 0001951238 · Chief Business Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 136,380

F2 · price: The weighted average sale price for the transaction reported was $14.1346, and the range of prices were between $13.95 and $14.35. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each price will be provided.

Read SEC document
December 05, 2024 Filed Dec 7, 2024 00:15 UTC
Chakma JustinChief Business Officer
Exercise / conversionCommon Stock 49,640 $0.84 $41,697.60
Disclosure

SEC source: 0001415889-24-028567 · form4-12072024_121247.xml · nonDerivative · entry 3

Chakma Justin · CIK 0001951238 · Chief Business Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 186,020

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
December 04, 2024 Filed Dec 5, 2024 02:40 UTC Exercise / conversionStock Option (Right to Buy) · Derivative 14,772 $0.00 Strike: $3.15 $0.00
Disclosure

SEC source: 0001415889-24-028350 · form4-12042024_091203.xml · derivative · entry 14

Shawver Laura · CIK 0001551891 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 59,064

Underlying: Common Stock · 14,772 shares

Expires 2032-05-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F6 · derivative.exercise_date: Immediately exercisable.

Read SEC document
December 04, 2024 Filed Dec 5, 2024 02:40 UTC SaleCommon Stock 14,772 $13.75 $203,109.09
Disclosure

SEC source: 0001415889-24-028350 · form4-12042024_091203.xml · nonDerivative · entry 9

Shawver Laura · CIK 0001551891 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 210,346

F1 · kind: The shares reported on this Form 4 were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 16, 2024.

F5 · price: The weighted average sale price for the transaction reported was $13.7496 and the range of prices were between $13.39 and $14.00. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.

Read SEC document
December 04, 2024 Filed Dec 5, 2024 02:40 UTC Exercise / conversionCommon Stock 14,772 $3.15 $46,531.80
Disclosure

SEC source: 0001415889-24-028350 · form4-12042024_091203.xml · nonDerivative · entry 8

Shawver Laura · CIK 0001551891 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 225,118

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
December 04, 2024 Filed Dec 5, 2024 02:40 UTC
Karas EricChief Commercial Officer
Exercise / conversionStock Option (Right to Buy) · Derivative 6,283 $0.00 Strike: $1.50 $0.00
Disclosure

SEC source: 0001415889-24-028349 · form4-12042024_091201.xml · derivative · entry 6

Karas Eric · CIK 0001951287 · Chief Commercial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 584,588

Underlying: Common Stock · 6,283 shares

Expires 2032-05-23

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: Immediately exercisable.

Read SEC document
December 04, 2024 Filed Dec 5, 2024 02:40 UTC
Karas EricChief Commercial Officer
SaleCommon Stock 6,283 $14.00 $87,962.00
Disclosure

SEC source: 0001415889-24-028349 · form4-12042024_091201.xml · nonDerivative · entry 4

Karas Eric · CIK 0001951287 · Chief Commercial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 5,693

F1 · kind: The shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 26, 2024.

Read SEC document
December 04, 2024 Filed Dec 5, 2024 02:40 UTC
Karas EricChief Commercial Officer
Exercise / conversionCommon Stock 6,283 $1.50 $9,424.50
Disclosure

SEC source: 0001415889-24-028349 · form4-12042024_091201.xml · nonDerivative · entry 3

Karas Eric · CIK 0001951287 · Chief Commercial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 11,976

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
December 04, 2024 Filed Dec 7, 2024 00:15 UTC
Chakma JustinChief Business Officer
Exercise / conversionStock Option (Right to Buy) · Derivative 45,000 $0.00 Strike: $0.84 $0.00
Disclosure

SEC source: 0001415889-24-028567 · form4-12072024_121247.xml · derivative · entry 7

Chakma Justin · CIK 0001951238 · Chief Business Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 149,640

Underlying: Common Stock · 45,000 shares

Expires 2029-07-04

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: Immediately exercisable.

Read SEC document
December 04, 2024 Filed Dec 7, 2024 00:15 UTC
Chakma JustinChief Business Officer
SaleCommon Stock 45,000 $13.95 $627,943.50
Disclosure

SEC source: 0001415889-24-028567 · form4-12072024_121247.xml · nonDerivative · entry 2

Chakma Justin · CIK 0001951238 · Chief Business Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 136,380

F1 · price: The weighted average sale price for the transaction reported was $13.9543, and the range of prices were between $13.77 and $14.28. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each price will be provided.

Read SEC document
December 04, 2024 Filed Dec 7, 2024 00:15 UTC
Chakma JustinChief Business Officer
Exercise / conversionCommon Stock 45,000 $0.84 $37,800.00
Disclosure

SEC source: 0001415889-24-028567 · form4-12072024_121247.xml · nonDerivative · entry 1

Chakma Justin · CIK 0001951238 · Chief Business Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 181,380

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
December 03, 2024 Filed Dec 5, 2024 02:45 UTC
Chakma JustinChief Business Officer
Exercise / conversionStock Option (Right to Buy) · Derivative 41,740 $0.00 Strike: $0.84 $0.00
Disclosure

SEC source: 0001415889-24-028351 · form4-12042024_091201.xml · derivative · entry 8

Chakma Justin · CIK 0001951238 · Chief Business Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 194,640

Underlying: Common Stock · 41,740 shares

Expires 2029-07-04

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: Immediately exercisable.

F3 · derivative.underlying: Immediately exercisable.

Read SEC document
December 03, 2024 Filed Dec 5, 2024 02:45 UTC
Chakma JustinChief Business Officer
Exercise / conversionStock Option (Right to Buy) · Derivative 3,260 $0.00 Strike: $0.84 $0.00
Disclosure

SEC source: 0001415889-24-028351 · form4-12042024_091201.xml · derivative · entry 7

Chakma Justin · CIK 0001951238 · Chief Business Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 3,260 shares

Expires 2029-12-16

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: Immediately exercisable.

Read SEC document
December 03, 2024 Filed Dec 5, 2024 02:45 UTC
Chakma JustinChief Business Officer
SaleCommon Stock 45,000 $13.19 $593,401.50
Disclosure

SEC source: 0001415889-24-028351 · form4-12042024_091201.xml · nonDerivative · entry 5

Chakma Justin · CIK 0001951238 · Chief Business Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 136,380

F2 · price: The weighted average sale price for the transaction reported was $13.1867, and the range of prices were between $13.00 and $13.38. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each price will be provided.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.